Choreic movements induced by cibenzoline: an Ic class antiarrhythmic effect?
Devos
D
D
Department of Neurology, Service de Neurologie et Pathologie du Mouvement, Hôpital Salengro, Lille, France.
Defebvre
L
L
Destée
A
A
Caron
J
J
D000368:Aged; D000889:Anti-Arrhythmia Agents / Q000009:adverse effects*; D001145:Arrhythmias, Cardiac / Q000188:drug therapy; D002819:Chorea / Q000139:chemically induced; D018492:Dopamine Antagonists / Q000009:adverse effects*; D004409:Dyskinesia, Drug-Induced / Q000503:physiopathology*; D004421:Dystonia / Q000139:chemically induced; D005260:Female; D005424:Flecainide / Q000009:adverse effects; D006801:Humans; D007093:Imidazoles / Q000009:adverse effects*; D007473:Ion Channels / Q000187:drug effects; D010138:Pacemaker, Artificial; D011188:Potassium / Q000378:metabolism; D012074:Remission Induction; D013469:Sulpiride / Q000009:adverse effects
D000889:Anti-Arrhythmia Agents; D018492:Dopamine Antagonists; D007093:Imidazoles; D007473:Ion Channels; D013469:Sulpiride; D005424:Flecainide; D011188:Potassium; C032151:cifenline